S&P 500   4,223.57 (+0.43%)
DOW   33,027.71 (-0.20%)
QQQ   353.05 (+1.33%)
AAPL   177.98 (+1.45%)
MSFT   333.41 (+0.16%)
META   265.14 (+1.18%)
GOOGL   124.11 (-0.40%)
AMZN   122.54 (+2.02%)
TSLA   201.57 (+4.35%)
NVDA   406.60 (+4.40%)
NIO   7.80 (+1.30%)
BABA   80.40 (-0.70%)
AMD   128.97 (+1.53%)
T   15.48 (-0.13%)
F   12.72 (+5.21%)
MU   73.55 (-0.51%)
CGC   0.87 (-0.66%)
GE   102.72 (-0.02%)
DIS   88.71 (+0.48%)
AMC   4.71 (+1.51%)
PFE   37.17 (-1.14%)
PYPL   60.91 (+1.15%)
NFLX   401.63 (+6.00%)
S&P 500   4,223.57 (+0.43%)
DOW   33,027.71 (-0.20%)
QQQ   353.05 (+1.33%)
AAPL   177.98 (+1.45%)
MSFT   333.41 (+0.16%)
META   265.14 (+1.18%)
GOOGL   124.11 (-0.40%)
AMZN   122.54 (+2.02%)
TSLA   201.57 (+4.35%)
NVDA   406.60 (+4.40%)
NIO   7.80 (+1.30%)
BABA   80.40 (-0.70%)
AMD   128.97 (+1.53%)
T   15.48 (-0.13%)
F   12.72 (+5.21%)
MU   73.55 (-0.51%)
CGC   0.87 (-0.66%)
GE   102.72 (-0.02%)
DIS   88.71 (+0.48%)
AMC   4.71 (+1.51%)
PFE   37.17 (-1.14%)
PYPL   60.91 (+1.15%)
NFLX   401.63 (+6.00%)
S&P 500   4,223.57 (+0.43%)
DOW   33,027.71 (-0.20%)
QQQ   353.05 (+1.33%)
AAPL   177.98 (+1.45%)
MSFT   333.41 (+0.16%)
META   265.14 (+1.18%)
GOOGL   124.11 (-0.40%)
AMZN   122.54 (+2.02%)
TSLA   201.57 (+4.35%)
NVDA   406.60 (+4.40%)
NIO   7.80 (+1.30%)
BABA   80.40 (-0.70%)
AMD   128.97 (+1.53%)
T   15.48 (-0.13%)
F   12.72 (+5.21%)
MU   73.55 (-0.51%)
CGC   0.87 (-0.66%)
GE   102.72 (-0.02%)
DIS   88.71 (+0.48%)
AMC   4.71 (+1.51%)
PFE   37.17 (-1.14%)
PYPL   60.91 (+1.15%)
NFLX   401.63 (+6.00%)
S&P 500   4,223.57 (+0.43%)
DOW   33,027.71 (-0.20%)
QQQ   353.05 (+1.33%)
AAPL   177.98 (+1.45%)
MSFT   333.41 (+0.16%)
META   265.14 (+1.18%)
GOOGL   124.11 (-0.40%)
AMZN   122.54 (+2.02%)
TSLA   201.57 (+4.35%)
NVDA   406.60 (+4.40%)
NIO   7.80 (+1.30%)
BABA   80.40 (-0.70%)
AMD   128.97 (+1.53%)
T   15.48 (-0.13%)
F   12.72 (+5.21%)
MU   73.55 (-0.51%)
CGC   0.87 (-0.66%)
GE   102.72 (-0.02%)
DIS   88.71 (+0.48%)
AMC   4.71 (+1.51%)
PFE   37.17 (-1.14%)
PYPL   60.91 (+1.15%)
NFLX   401.63 (+6.00%)
OTCMKTS:IMEXF

Imagin Medical (IMEXF) Stock Forecast, Price & News

C$0.07
0.00 (-3.85%)
(As of 05/26/2023 08:48 PM ET)
Compare
Today's Range
C$0.07
C$0.07
50-Day Range
C$0.07
C$0.15
52-Week Range
C$0.07
C$0.38
Volume
22,200 shs
Average Volume
5,446 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

IMEXF stock logo

About Imagin Medical (OTCMKTS:IMEXF) Stock

Imagin Medical, Inc. engages in the research, development, and commercialization in the device and instrumentation medical technology industry. Its products include i/Blue Imaging System™ for Bladder Cancer and enCAGE Coil™ Precision Ablation System for Prostate Cancer. The company was founded on April 30, 1987 and is headquartered in Vancouver, Canada.

Receive IMEXF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Imagin Medical and its competitors with MarketBeat's FREE daily newsletter.

IMEXF Stock News Headlines

Medical Imaging Informatics Market Size, 2030
The Graphite Shortage Story You're Not Being Told
Graphite demand for EV batteries is expected to increase 10X from 2020 to 2030. And today, with NO graphite-producing mines in N. America, China has a stranglehold on our graphite supply. That's why the U.S. government is spending billions of dollars to ensure an adequate domestic supply of this metal that's vital for energy independence and national security.
Medical Wide field Imaging Systems Market, 2030
The Graphite Shortage Story You're Not Being Told
Graphite demand for EV batteries is expected to increase 10X from 2020 to 2030. And today, with NO graphite-producing mines in N. America, China has a stranglehold on our graphite supply. That's why the U.S. government is spending billions of dollars to ensure an adequate domestic supply of this metal that's vital for energy independence and national security.
Imagin Medical Inc. (IMEXF)
Imagin Medical Inc
MediMatrix acquired by California-based company ASG
Imagin Medical Announces Stock Option Grants
See More Headlines
Receive IMEXF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Imagin Medical and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Diagnostics & Research
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:IMEXF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • E. James Hutchens
    President, CEO & Non-Independent Director
  • Michael G. Vergano
    Operations Director
  • John F. Vacha
    Chief Financial Officer & Secretary
  • Pam Papineau
    Director-Regulatory Affairs













IMEXF Stock - Frequently Asked Questions

How have IMEXF shares performed in 2023?

Imagin Medical's stock was trading at C$0.20 on January 1st, 2023. Since then, IMEXF shares have decreased by 64.3% and is now trading at C$0.07.
View the best growth stocks for 2023 here
.

What is Imagin Medical's stock symbol?

Imagin Medical trades on the OTCMKTS under the ticker symbol "IMEXF."

How do I buy shares of Imagin Medical?

Shares of IMEXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Imagin Medical's stock price today?

One share of IMEXF stock can currently be purchased for approximately C$0.07.

How can I contact Imagin Medical?

Imagin Medical's mailing address is 890 Pender St W Suite 600, VANCOUVER, BC V6C 1J9, Canada. The official website for the company is imaginmedical.com. The company can be reached via phone at (833) 246-2446.

This page (OTCMKTS:IMEXF) was last updated on 5/30/2023 by MarketBeat.com Staff

My Account -